Xvivo Perfusion AB (publ) (XVIPF)

Xvivo Perfusion AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	315.87	415.52	546.09	246.55	398.7	354.24
Cash & Short-Term Investments	315.87	415.52	546.09	246.55	398.7	354.24
Cash Growth	-38.20%	-23.91%	121.50%	-38.16%	12.55%	121.47%
Accounts Receivable	184.67	117.29	98.13	94.5	52.04	40.18
Other Receivables	-	23.74	20.25	9.76	11.88	3.52
Receivables	184.67	141.04	118.37	104.26	63.91	43.7
Inventory	225.88	227.41	141.6	106.57	77.59	59.35
Prepaid Expenses	-	29.11	20.34	10.14	7.34	5.94
Total Current Assets	726.42	813.08	826.41	467.51	547.53	463.23
Property, Plant & Equipment	151.81	149.04	97.55	47.58	26.3	21.33
Long-Term Investments	32.65	0.9	0.58	0.41	1.16	0.75
Goodwill	636.84	682.48	591.39	625.32	460.23	223.94
Other Intangible Assets	43.74	48.7	30.46	8.49	8.66	6.75
Long-Term Deferred Tax Assets	-	32.45	50.71	39.27	42.17	40.33
Long-Term Deferred Charges	703.63	676.09	598.51	544.51	456.55	393.97
Total Assets	2,295	2,403	2,196	1,733	1,543	1,150
Accounts Payable	-	39.45	36.05	38.47	21.45	14.47
Accrued Expenses	-	85.08	68.94	52.65	46.96	48.9
Current Portion of Leases	9.02	10.92	10.27	5.55	4.2	3.93
Current Income Taxes Payable	-	11.93	11.87	1.28	0.3	-
Current Unearned Revenue	-	13.47	3.69	3.17	3.01	3.72
Other Current Liabilities	130.61	16.67	3.66	33.77	28.6	1.24
Total Current Liabilities	139.63	177.51	134.49	134.9	104.52	72.25
Long-Term Leases	20.29	23.13	21.17	4.46	1.52	3.29
Long-Term Deferred Tax Liabilities	-	27.85	29.29	25.77	25.08	24.85
Other Long-Term Liabilities	42.76	17.48	65.62	137.83	126.02	41.46
Total Liabilities	202.68	245.97	250.57	302.95	257.15	141.85
Common Stock	0.81	0.81	0.81	0.76	0.75	0.73
Additional Paid-In Capital	1,773	1,772	1,764	1,314	1,253	1,007
Retained Earnings	279.36	291.76	119.57	27.75	9.28	1.13
Comprehensive Income & Other	39.52	92.19	60.89	87.78	22.09	-0.18
Shareholders' Equity	2,092	2,157	1,945	1,430	1,285	1,008
Total Liabilities & Equity	2,295	2,403	2,196	1,733	1,543	1,150
Total Debt	29.31	34.04	31.44	10.01	5.72	7.21
Net Cash (Debt)	286.56	381.48	514.65	236.54	392.98	347.02
Net Cash Growth	-40.33%	-25.88%	117.58%	-39.81%	13.24%	124.76%
Net Cash Per Share	9.04	12.05	17.19	8.01	13.58	12.77
Filing Date Shares Outstanding	31.5	31.5	31.5	29.83	29.5	28.72
Total Common Shares Outstanding	31.5	31.5	31.5	29.83	29.5	28.72
Working Capital	586.79	635.57	691.92	332.61	443.01	390.98
Book Value Per Share	66.43	68.47	61.75	47.94	43.58	35.11
Tangible Book Value	1,412	1,426	1,323	796.33	816.56	777.77
Tangible Book Value Per Share	44.82	45.26	42.01	26.69	27.68	27.08
Machinery	-	217.57	153.61	98.52	68.04	58.77

Source: S&P Global Market Intelligence. Standard template. Financial Sources.